Key player · Company profile
Glanbia PLC
Named as a key player in 264 of our reports, across 33 regions and countries.
Named as a key player in 264 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 8
Brazil 8
Canada 8
China 8
Ecuador 8
Egypt 8
France 8
Germany 8
Hong Kong 8
India 8
Italy 8
Japan 8
Kenya 8
Malaysia 8
Mexico 8
New Zealand 8
Philippines 8
Russia 8
Saudi Arabia 8
Singapore 8
South Africa 8
Spain 8
Thailand 8
UAE 8
UK 8
US 8| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Nutritional Supplements | OTC & Nutraceuticals | $385 Bn | 6.8% |
| Dietary Supplements | OTC & Nutraceuticals | $308 Bn | 6.2% |
| Sports Nutrition | OTC & Nutraceuticals | $52 Bn | 7.9% |
| Protein Supplement | OTC & Nutraceuticals | $20 Bn | 7.4% |
| Plant-Based Supplements | OTC & Nutraceuticals | $12.3 Bn | 8% |
| Creatine | OTC & Nutraceuticals | $600 Mn | 6.3% |
| Immune Health Supplement | OTC & Nutraceuticals | – | – |
| Weight Management Supplement | OTC & Nutraceuticals | – | – |
Named as key players in the same markets as Glanbia PLC (number of shared markets).
PepsiCo3 shared markets
Abbott Laboratories2 shared markets
Bayer AG2 shared markets
Cardiff Sports Nutrition Ltd2 shared markets
Cliff Bar & Company2 shared markets